At the center of medical innovation, Medtech CDMOs are powering growth through strategic M&A, rising venture capital interest and next-gen technologies. With growing demand for AI-enabled devices and minimally invasive solutions, the sector is evolving rapidly, particularly in the U.S., where market momentum outpaces Europe’s more fragmented landscape. As regulatory complexity increases, CDMOs are becoming essential partners for first-time launches and scalable growth.

What You'll Learn:

• Market dynamics driven by M&A activity, including major deals like J&J’s acquisition of Shockwave and V-Wave
• Growth areas fueled by venture capital, AI and minimally invasive technologies
• The expanding role of CDMOs in regulatory support and commercialization
• U.S. market strength versus European structural hurdles and consolidation potential
• Capital market insights, from IPOs to private equity opportunities

Medtech CDMOs offer a compelling opportunity for investors, operators and innovators to accelerate advancement in the healthcare ecosystem.

Download the Report